Tag: Johnson & Johnson

Johnson & Johnson Announces Launch of Africa Innovation Challenge to Support Continent’s Entrepreneurs and Develop Local Consumer Health Solutions

| November 1, 2016

Challenge Reflects Company’s Comprehensive Approach to Advancing Health and Innovation on the Continent

CAPE TOWN, South Africa, Nov. 1, 2016 /PRNewswire/ — As part of its longstanding commitment to Africa, Johnson & Johnson (NYSE: JNJ) today announced the launch of …

Continue Reading

Johnson & Johnson lance un appel aux idées innovantes afin de réduire les infections au VIH en Afrique subsaharienne

| February 18, 2016

Les partenaires DREAMS annoncent un défi de l’innovation de 85 millions $ axé sur les solutions pour les adolescentes et les jeunes femmes

NEW BRUNSWICK, New Jersey, le 18 février 2016 /PRNewswire/ — Aujourd’hui, Johnson & Johnson (NYSE : JNJ) …

Continue Reading

Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa

| February 18, 2016

DREAMS Partners Announce $85 Million Innovation Challenge Focused on Solutions for Adolescent Girls and Young Women

NEW BRUNSWICK, New Jersey, Feb. 17, 2016 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today issued a call for innovative ideas as part of …

Continue Reading

Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen

| January 6, 2015

– Company Has Produced More Than 400,000 Vaccine Regimens for Use in Large-Scale Clinical Trials by April 2015

NEW BRUNSWICK, New Jersey, Jan. 6, 2015 / PRNewswire / Asianet-Pakistan - Johnson & Johnson (NYSE: JNJ) today announced the start of …

Continue Reading